{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Mahwah",
      "state": "NJ",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA077651"
        ],
        "brand_name": [
          "ZONISAMIDE"
        ],
        "generic_name": [
          "ZONISAMIDE"
        ],
        "manufacturer_name": [
          "Glenmark Pharmaceuticals Inc., USA"
        ],
        "product_ndc": [
          "68462-128",
          "68462-129",
          "68462-130"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "ZONISAMIDE"
        ],
        "rxcui": [
          "314285",
          "403966",
          "403967"
        ],
        "spl_id": [
          "c00ccc2d-52c6-4a11-a310-d8db25ca3928"
        ],
        "spl_set_id": [
          "fe15e56e-8b86-4a65-825c-31d37dd81612"
        ],
        "package_ndc": [
          "68462-128-01",
          "68462-128-05",
          "68462-129-01",
          "68462-129-05",
          "68462-130-01",
          "68462-130-05"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0368462130018",
          "0368462129012",
          "0368462128015"
        ],
        "nui": [
          "N0000175753",
          "N0000008486",
          "M0020790",
          "N0000000235",
          "N0000185503"
        ],
        "pharm_class_epc": [
          "Anti-epileptic Agent [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
        ],
        "pharm_class_cs": [
          "Sulfonamides [CS]"
        ],
        "pharm_class_moa": [
          "Carbonic Anhydrase Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]"
        ],
        "unii": [
          "459384H98V"
        ]
      },
      "product_type": "Drugs",
      "event_id": "88591",
      "recalling_firm": "Glenmark Pharmaceuticals Inc., USA",
      "address_1": "750 Corporate Dr",
      "address_2": "",
      "postal_code": "07430-2009",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide.",
      "recall_number": "D-0825-2021",
      "product_description": "Zonisamide Capsules USP 50 mg 100 Capsules Rx Only NDC 68462-129-01 Manufactured by: Glenmark Pharmaceuticals Inc., USA Monroe, NC 28110 Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430",
      "product_quantity": "15936 bottles",
      "reason_for_recall": "CGMP Deviations",
      "recall_initiation_date": "20210827",
      "center_classification_date": "20210921",
      "termination_date": "20231004",
      "report_date": "20210929",
      "code_info": "Lots: 29190043 Exp. 05/31/2022; 29190044 Exp. 05/31/2022; 29190045 Exp. 05/31/2022",
      "more_code_info": ""
    }
  ]
}